Assessment of Human Colorectal Biopsies by 1H MRS: Correlation with Histopathology
Overview
Affiliations
Samples (3 mm3) of histopathologically normal (n = 15) and carcinomatous tissue (n = 15) were obtained from colectomy specimens and examined by 1H MRS. A combination of one- and two-dimensional spectra, obtained with appropriate acquisition and processing parameters, provide multiple diagnostic parameters allowing the distinction between normal and carcinomatous tissue. The diagnostic parameters include resonances from choline, choline-based, and other metabolites, cell surface fucosylation, and altered lipid profiles. Tissues histopathologically classified as normal, while remaining distinct from the malignant spectral profile, were found to fit into two categories, one of which had some of the spectral characteristics of malignancy. These results indicate that 1H MRS identifies abnormal colorectal mucosa, which is not morphologically manifest. Such abnormalities have been reported previously to exist in premalignant colorectal tissue by monoclonal antibody studies. Collectively, these results suggest that a clinical study of colorectal biopsies by 1H MRS could provide support for the use of MRS as an adjunct to current pathological procedures.
Deng L, Gu H, Zhu J, Gowda G, Djukovic D, Chiorean E Anal Chem. 2016; 88(16):7975-83.
PMID: 27437783 PMC: 5450811. DOI: 10.1021/acs.analchem.6b00885.
Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage.
Gu H, Zhang P, Zhu J, Raftery D Anal Chem. 2015; 87(24):12355-62.
PMID: 26579731 PMC: 5437843. DOI: 10.1021/acs.analchem.5b03812.
MRS-based Metabolomics in Cancer Research.
Bezabeh T, Ijare O, Nikulin A, Somorjai R, Smith I Magn Reson Insights. 2014; 7:1-14.
PMID: 25114549 PMC: 4122556. DOI: 10.4137/MRI.S13755.
A prospective study of serum metabolites and colorectal cancer risk.
Cross A, Moore S, Boca S, Huang W, Xiong X, Stolzenberg-Solomon R Cancer. 2014; 120(19):3049-57.
PMID: 24894841 PMC: 5819589. DOI: 10.1002/cncr.28799.
Non-invasive fecal metabonomic detection of colorectal cancer.
Phua L, Chue X, Koh P, Cheah P, Ho H, Chan E Cancer Biol Ther. 2014; 15(4):389-97.
PMID: 24424155 PMC: 3979816. DOI: 10.4161/cbt.27625.